158 related articles for article (PubMed ID: 10205607)
21. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.
Han HK; Oh DM; Amidon GL
Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889
[TBL] [Abstract][Full Text] [Related]
22. [Absorption of papaverine, laudanosine and cepharanthine across human intestine by using human Caco-2 cells monolayers model].
Ma L; Yang XW
Yao Xue Xue Bao; 2008 Feb; 43(2):202-7. PubMed ID: 18507350
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of PepT1 transport of food-derived antihypertensive peptides, Ile-Pro-Pro and Leu-Lys-Pro using in vitro, ex vivo and in vivo transport models.
Gleeson JP; Brayden DJ; Ryan SM
Eur J Pharm Biopharm; 2017 Jun; 115():276-284. PubMed ID: 28315445
[TBL] [Abstract][Full Text] [Related]
24. Derivatives of melphalan designed to enhance drug accumulation in cancer cells.
Kupczyk-Subotkowska L; Tamura K; Pal D; Sakaeda T; Siahaan TJ; Stella VJ; Borchardt RT
J Drug Target; 1997; 4(6):359-70. PubMed ID: 9239576
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of a novel Caco-2 cell perfusion system. I. In vitro prediction of the absorption potential of passively diffused compounds.
Masungi C; Borremans C; Willems B; Mensch J; Van Dijck A; Augustijns P; Brewster ME; Noppe M
J Pharm Sci; 2004 Oct; 93(10):2507-21. PubMed ID: 15349960
[TBL] [Abstract][Full Text] [Related]
26. Monolayers of IEC-18 cells as an in vitro model for screening the passive transcellular and paracellular transport across the intestinal barrier: comparison of active and passive transport with the human colon carcinoma Caco-2 cell line.
Versantvoort CH; Ondrewater RC; Duizer E; Van de Sandt JJ; Gilde AJ; Groten JP
Environ Toxicol Pharmacol; 2002 Jul; 11(3-4):335-44. PubMed ID: 21782616
[TBL] [Abstract][Full Text] [Related]
27. Absorption and transport of pachymic acid in the human intestinal cell line Caco-2 monolayers.
Zheng Y; Yang XW
Zhong Xi Yi Jie He Xue Bao; 2008 Jul; 6(7):704-10. PubMed ID: 18601852
[TBL] [Abstract][Full Text] [Related]
28. Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics.
Cao F; Gao Y; Wang M; Fang L; Ping Q
Mol Pharm; 2013 Apr; 10(4):1378-87. PubMed ID: 23339520
[TBL] [Abstract][Full Text] [Related]
29. Transepithelial flux of early and advanced glycation compounds across Caco-2 cell monolayers and their interaction with intestinal amino acid and peptide transport systems.
Grunwald S; Krause R; Bruch M; Henle T; Brandsch M
Br J Nutr; 2006 Jun; 95(6):1221-8. PubMed ID: 16768847
[TBL] [Abstract][Full Text] [Related]
30. Transepithelial transport of 6-O-caffeoylsophorose across Caco-2 cell monolayers.
Phuong HL; Qiu J; Kuwahara T; Fukui K; Yoshiyama K; Matsugano K; Terahara N; Matsui T
Food Chem; 2013 May; 138(1):101-6. PubMed ID: 23265462
[TBL] [Abstract][Full Text] [Related]
31. Caco-2 cell permeability assays to measure drug absorption.
van Breemen RB; Li Y
Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):175-85. PubMed ID: 16922635
[TBL] [Abstract][Full Text] [Related]
32. Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells.
Walgren RA; Walle UK; Walle T
Biochem Pharmacol; 1998 May; 55(10):1721-7. PubMed ID: 9634009
[TBL] [Abstract][Full Text] [Related]
33. Transport of a Novel Angiotensin-I-Converting Enzyme Inhibitory Peptide Ala-His-Leu-Leu Across Human Intestinal Epithelial Caco-2 Cells.
Li Y; Zhao J; Liu X; Xia X; Wang Y; Zhou J
J Med Food; 2017 Mar; 20(3):243-250. PubMed ID: 28296590
[TBL] [Abstract][Full Text] [Related]
34. Transport Versus Hydrolysis: Reassessing Intestinal Assimilation of Di- and Tripeptides by LC-MS/MS Analysis.
Rohm F; Daniel H; Spanier B
Mol Nutr Food Res; 2019 Nov; 63(21):e1900263. PubMed ID: 31394017
[TBL] [Abstract][Full Text] [Related]
35. Biological analysis of constituents in Spatholobi Caulis by UFLC-MS/MS: Enhanced quantification and application to permeability properties study in Caco-2 cell monolayer model.
Liu XY; Zhang YB; Yang XW; Wu XW; Yang YF; Xu W; Wan MQ; Gong Y; Liu NF; Zhang P
J Pharm Biomed Anal; 2023 Mar; 226():115235. PubMed ID: 36680806
[TBL] [Abstract][Full Text] [Related]
36. Transport of Val-Leu-Pro-Val-Pro in human intestinal epithelial (Caco-2) cell monolayers.
Lei L; Sun H; Liu D; Liu L; Li S
J Agric Food Chem; 2008 May; 56(10):3582-6. PubMed ID: 18442243
[TBL] [Abstract][Full Text] [Related]
37. Transport characteristics of fexofenadine in the Caco-2 cell model.
Petri N; Tannergren C; Rungstad D; Lennernäs H
Pharm Res; 2004 Aug; 21(8):1398-404. PubMed ID: 15359574
[TBL] [Abstract][Full Text] [Related]
38. Enhanced permeability of the antimicrobial agent 2,5-bis(4-amidinophenyl)furan across Caco-2 cell monolayers via its methylamidoidme prodrug.
Zhou L; Lee K; Thakker DR; Boykin DW; Tidwell RR; Hall JE
Pharm Res; 2002 Nov; 19(11):1689-95. PubMed ID: 12458675
[TBL] [Abstract][Full Text] [Related]
39. Determination of in vitro permeability of drug candidates through a caco-2 cell monolayer by liquid chromatography/tandem mass spectrometry.
Wang Z; Hop CE; Leung KH; Pang J
J Mass Spectrom; 2000 Jan; 35(1):71-6. PubMed ID: 10633236
[TBL] [Abstract][Full Text] [Related]
40. Intestinal transport of 3,6'-disinapoylsucrose, a major active component of Polygala tenuifolia, using Caco-2 cell monolayer and in situ rat intestinal perfusion models.
Chen Y; Liu X; Pan R; Zhu X; Steinmetz A; Liao Y; Wang N; Peng B; Chang Q
Planta Med; 2013 Oct; 79(15):1434-9. PubMed ID: 24043590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
